H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Alphatec Holdings (ATEC) today and set a price target of $4. The company’s shares closed on Friday at $2.49.
Ramakanth commented:
“We have updated our model to reflect the reported financials and management guidance. For 2019, we project total revenues of $101M and a net loss of $0.62 per share.”
According to TipRanks.com, Ramakanth has 0 stars on 0-5 star ranking scale with an average return of -3.2% and a 33.3% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Collplant Holdings Ltd, Gritstone Oncology Inc, and Leap Therapeutics Inc.
Currently, the analyst consensus on Alphatec Holdings is a Moderate Buy with an average price target of $5.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $4.21 and a one-year low of $1.18. Currently, Alphatec Holdings has an average volume of 471.3K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alphatec Holdings, Inc. designs, develops, and markets spinal fusion technology products and solutions for the treatment of spinal disorders. The company products portfolio include biologics, cervical, interbody, minimally invasive surgery, and thoracolumbar. It operates through the United States and International geographical segments.
